Rigel Pharmaceuticals, Inc. (RIGL) – What Are Analysts Saying About This Stock?

Rigel Pharmaceuticals: Turning Big Pharma's Castoffs Into A Growth Engine (NASDAQ:RIGL)

Rigel Pharmaceuticals is building an oncology growth platform with VEPPANU and undervalued shares. Check out why RIGL stock is a buy.

Rigel Pharmaceuticals, Inc. (RIGL) – What Are Analysts Saying About This Stock?

Shares of Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL – Get Free Report) have received an average recommendation of “Hold” from the seven ratings firms that are covering the firm, Marketbeat reports. One analyst has rated the stock with a sell rating, two have given a hold rating and four have assigned a buy rating to the company. […]